Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
TUSQ-D
Synonyms :
amylmetacresol/dextromethorphan hydrobromide
Class :
Cough and cold preparations
Dosage Forms & StrengthsÂ
Lozenge Â
0.6 mg/5 mg Â
Put 1 lozenge in the mouth and sucked slowly every 4 hours
Not more than 12 lozenges in a day
Dosage Forms & StrengthsÂ
Lozenge Â
0.6 mg/5 mg Â
(amylmetacresol/dextromethorphan hydrobromide)Â
for 6 to 12 years old:
Put 1 lozenge in the mouth and sucked slowly every 4 hours
Not more than 6 lozenges in a day
for >12 years old:
Put 1 lozenge in the mouth and sucked slowly every 4 hours
Not more than 12 lozenges in a day
Refer to adult dosingÂ
Actions and SpectrumÂ
amymetacresol is an antiseptic and mild local anesthetic. It is often used in throat lozenges or sprays to help alleviate throat discomfort and irritation due to sore throat. Its primary action is to reduce the sensation of pain and irritation in the throat.Â
dextromethorphan hydrobromide is a cough suppressant, which means it helps to reduce the urge to cough. It works by affecting the cough reflex in the brain. Its acts on the central nervous system to inhibit the cough reflex, providing relief from dry and irritating coughs.
Frequency not defined Â
Joint painÂ
Stomachache Â
HeadacheÂ
ConfusionÂ
Facial swellingÂ
TachycardiaÂ
ModerateÂ
RashÂ
Difficulty breathingÂ
NervousnessÂ
DrowsinessÂ
HallucinationsÂ
MildÂ
Nausea or vomitingÂ
DizzinessÂ
RestlessnessÂ
Black Box WarningÂ
NoneÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: Excretion into human milk is unknown Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
amylmetacresol has antiseptic properties, which means it helps inhibit the growth of microorganisms such as bacteria and fungi. Â
dextromethorphan hydrobromide acts on the central nervous system i.e., the cough center in the brain, to reduce the urge to cough.Â
PharmacodynamicsÂ
Limited information available Â
PharmacokineticsÂ
Limited information available on ADMEÂ Â
AdministrationÂ
amylmetacresol and dextromethorphan hydrobromide combination drug is administered orally. Â
It is available in lozenges and capsules form.Â
Patient information leafletÂ
Generic Name: amylmetacresol/ dextromethorphan hydrobromide Â
Why do we use amylmetacresol/ dextromethorphan hydrobromide?Â
amylmetacresol and dextromethorphan hydrobromide combination drug are commonly used in relief from symptoms associated with respiratory infections, such as sore throat and dry cough.  Â
amylmetacresol is help in a sore throat and reduce discomfort by numbing the irritated tissues and inhibiting the growth of bacteria and fungi. dextromethorphan is a cough suppressant that acts on the central nervous system to reduce the urge to cough.Â